Literature DB >> 18627299

Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions.

Azza Eissa1, Eleftherios P Diamandis.   

Abstract

Human tissue kallikreins (KLKs) are the largest family of secreted serine protease endopeptidases encoded by 15 genes clustered on chromosome 19q13.4. Multiple KLK enzymes are co-localized in the upper stratum granulosum and stratum corneum of human epidermis, and in associated appendages such as hair follicle epithelia and sweat glands. Until recently, kallikrein proteolytic activity in the skin was exclusively attributed to KLK5 and KLK7. However, wider cutaneous roles of kallikreins became evident in recent years as the proposal of KLK proteolytic activation cascades emerged. We postulate that these proteolytic enzymes may serve as promiscuous mediators of different skin barrier functions, since they are capable of proteolysing different substrates that govern skin desquamation, antimicrobial defense, and lipid permeability. Growing evidence now attests to potential kallikrein involvement in skin inflammation, pigmentation, and tumor suppression via their ability to target proteinase-activated receptor signaling pathways. Current knowledge on kallikrein roles in skin physiology and pathobiology is described in this review.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18627299     DOI: 10.1515/BC.2008.079

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  21 in total

1.  Induction of complement C3a receptor responses by kallikrein-related peptidase 14.

Authors:  Katerina Oikonomopoulou; Robert A DeAngelis; Hui Chen; Eleftherios P Diamandis; Morley D Hollenberg; Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

Review 2.  Unleashing the therapeutic potential of human kallikrein-related serine proteases.

Authors:  Ioannis Prassas; Azza Eissa; Gennadiy Poda; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

3.  Novel Biological Substrates of Human Kallikrein 7 Identified through Degradomics.

Authors:  Yijing Yu; Ioannis Prassas; Apostolos Dimitromanolakis; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

4.  Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors.

Authors:  Audrey Guillon-Munos; Katerina Oikonomopoulou; Noémie Michel; Chistopher R Smith; Agnès Petit-Courty; Sylvie Canepa; Pascale Reverdiau; Nathalie Heuzé-Vourc'h; Eleftherios P Diamandis; Yves Courty
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

5.  Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade.

Authors:  Azza Eissa; Vanessa Amodeo; Christopher R Smith; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2010-10-12       Impact factor: 5.157

6.  Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer.

Authors:  Fabien Gueugnon; Aurélia Barascu; Konstantinos Mavridis; Agnès Petit-Courty; Sylvain Marchand-Adam; Valérie Gissot; Andreas Scorilas; Serge Guyetant; Yves Courty
Journal:  Tumour Biol       Date:  2015-02-13

7.  The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human.

Authors:  Isabelle Schepens; Fabienne Jaunin; Nadja Begre; Ursula Läderach; Katrin Marcus; Takashi Hashimoto; Bertrand Favre; Luca Borradori
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

Review 8.  Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis.

Authors:  Sang Eun Lee; Se Kyoo Jeong; Seung Hun Lee
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

9.  Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid.

Authors:  Shin Morizane; Kenshi Yamasaki; Filamer D Kabigting; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2010-01-21       Impact factor: 8.551

10.  Hyperactivation of JAK1 tyrosine kinase induces stepwise, progressive pruritic dermatitis.

Authors:  Takuwa Yasuda; Toshiyuki Fukada; Keigo Nishida; Manabu Nakayama; Masashi Matsuda; Ikuo Miura; Teruki Dainichi; Shinji Fukuda; Kenji Kabashima; Shinji Nakaoka; Bum-Ho Bin; Masato Kubo; Hiroshi Ohno; Takanori Hasegawa; Osamu Ohara; Haruhiko Koseki; Shigeharu Wakana; Hisahiro Yoshida
Journal:  J Clin Invest       Date:  2016-04-25       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.